NKTX - Nkarta, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NKTX (1787400)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
28 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-07-16
NKTXHager Alicia J.GCS - Sale$8.00-3,396103,819-3%-$27,168
2024-06-18
NKTXTrager JamesChief Scientific OfficerS - Sale$5.60-456150,9590%-$2,554
2024-06-18
NKTXHastings Paul JCEOS - Sale$5.60-1,770240,737-1%-$9,912
2024-06-18
NKTXShook DavidChief Medical OfficerS - Sale$5.60-456116,5240%-$2,554
2024-06-18
NKTXHager Alicia J.GCS - Sale$5.60-727107,215-1%-$4,071
2024-06-18
NKTXBrandenberger RalphChief Technical OfficerS - Sale$5.60-22979,7430%-$1,282
D
2024-03-27
NKTXRa Capital Management, L.P.Dir, 10%P - Purchase$10.00+3,000,00010,805,129+38%+$30,000,000
2024-03-27
NKTXGeorge SimeonDirP - Purchase$10.00+2,000,0003,333,333+150%+$20,000,000
D
2024-03-01
NKTXBrandenberger RalphChief Technical OfficerS - Sale+OE$12.51-8,36779,972-9%-$104,671
2024-02-12
NKTXTrager JamesChief Scientific OfficerS - Sale$12.00-4,143149,415-3%-$49,716
2024-01-16
NKTXShook DavidChief Medical OfficerS - Sale$8.74-3,552114,980-3%-$31,044
2024-01-16
NKTXTrager JamesChief Scientific OfficerS - Sale$8.74-4,560153,558-3%-$39,854
2024-01-16
NKTXBrandenberger RalphChief Technical OfficerS - Sale$8.74-2,51281,576-3%-$21,955
2024-01-16
NKTXHastings Paul JCEOS - Sale$8.74-9,697390,507-2%-$84,752
2024-01-16
NKTXHager Alicia J.GCS - Sale$8.74-4,554107,942-4%-$39,802
2023-08-21
NKTXShook DavidChief Medical OfficerS - Sale$1.83-1,33160,532-2%-$2,436
2023-06-20
NKTXTrager JamesChief Scientific OfficerS - Sale$4.85-439100,1180%-$2,129
2023-06-20
NKTXBrandenberger RalphChief Technical OfficerS - Sale$4.85-22128,088-1%-$1,072
2023-06-20
NKTXHager Alicia J.GCS - Sale$4.85-70156,496-1%-$3,400
2023-06-20
NKTXShook DavidChief Medical OfficerS - Sale$4.85-43961,863-1%-$2,129
2023-06-20
NKTXMahmood NadirSee RemarksS - Sale$4.85-52685,776-1%-$2,551
2023-06-20
NKTXHastings Paul JCEOS - Sale$4.85-1,704313,402-1%-$8,264
D
2023-01-17
NKTXTrager JamesChief Scientific OfficerS - Sale+OE$5.49-1,11598,557-1%-$6,121
D
2023-01-17
NKTXShook DavidChief Medical OfficerS - Sale+OE$5.49-17560,3020%-$961
D
2023-01-17
NKTXMahmood NadirSee RemarksS - Sale+OE$5.49-1,12284,302-1%-$6,160
D
2023-01-17
NKTXHastings Paul JCEOS - Sale+OE$5.49-3,691313,106-1%-$20,264
D
2023-01-17
NKTXHager Alicia J.GCS - Sale+OE$5.49-1,10357,197-2%-$6,055
D
2023-01-17
NKTXBrandenberger RalphChief Technical OfficerS - Sale+OE$5.49-49128,309-2%-$2,696

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top